Aumolertinib with chemotherapy or alone compared with osimertinib in patients with EGFR-mutant non-small-cell lung cancer (TREBLE).

被引：0
|
作者：
Johnson, Melissa Lynne
Miller, Vincent A.
Patel, Suraj
Zhao, Yumin
Cheng, Li
Ali, Siraj Mahamed
Wooten, Michael
Daniel, Davey B.
机构：
[1] Cannon Res Inst, Tennessee Oncol, Nashville, TN USA
[2] EQRx, Cambridge, MA USA
[3] EQRx, Norcross, GA USA
[4] Tennessee Oncol, Chattanooga, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS9153
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer Reply
    Wu, Yi-Long
    Zhong, Wen-Zhao
    [J]. LANCET ONCOLOGY, 2018, 19 (03): : E127 - E127
  • [32] Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
    William Pao
    Juliann Chmielecki
    [J]. Nature Reviews Cancer, 2010, 10 : 760 - 774
  • [33] Multiple treatment modalities for brain metastasis in patients with EGFR-mutant non-small-cell lung cancer
    Wang, Haiyang
    Yu, Xiaoqing
    Fan, Yun
    Jiang, Youhua
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 2149 - 2155
  • [34] Osimertinib for EGFR-mutant non-small cell lung cancer: place in therapy and future perspectives
    Ricciuti, Biagio
    [J]. JOURNAL OF THORACIC DISEASE, 2019, 11 : S249 - S252
  • [35] Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
    Soei Gen
    Ichidai Tanaka
    Masahiro Morise
    Junji Koyama
    Yuta Kodama
    Akira Matsui
    Ayako Miyazawa
    Tetsunari Hase
    Yoshitaka Hibino
    Toshihiko Yokoyama
    Tomoki Kimura
    Norio Yoshida
    Mitsuo Sato
    Naozumi Hashimoto
    [J]. BMC Cancer, 22
  • [36] Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
    Gen, Soei
    Tanaka, Ichidai
    Morise, Masahiro
    Koyama, Junji
    Kodama, Yuta
    Matsui, Akira
    Miyazawa, Ayako
    Hase, Tetsunari
    Hibino, Yoshitaka
    Yokoyama, Toshihiko
    Kimura, Tomoki
    Yoshida, Norio
    Sato, Mitsuo
    Hashimoto, Naozumi
    [J]. BMC CANCER, 2022, 22 (01)
  • [37] Impact of sequential therapy with osimertinib on the overall survival in patients with EGFR-mutant non-small cell lung cancer
    Inomata, Minehiko
    Matsumoto, Masahiro
    Mizushima, Isami
    Hayashi, Kana
    Seto, Zenta
    Tokui, Kotaro
    Taka, Chihiro
    Okazawa, Seisuke
    Kambara, Kenta
    Imanishi, Shingo
    Miwa, Toshiro
    Hayashi, Ryuji
    Matsui, Shoko
    Tobe, Kazuyuki
    [J]. EGYPTIAN JOURNAL OF BRONCHOLOGY, 2022, 16 (01)
  • [38] Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis
    Chiang, Chi-Lu
    Ho, Hsiang-Ling
    Yeh, Yi-Chen
    Lee, Cheng-Chia
    Huang, Hsu-Ching
    Shen, Chia-, I
    Luo, Yung-Hung
    Chen, Yuh-Min
    Chiu, Chao-Hua
    Chou, Teh-Ying
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (01) : 5 - 14
  • [39] Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis
    Chi-Lu Chiang
    Hsiang-Ling Ho
    Yi-Chen Yeh
    Cheng-Chia Lee
    Hsu-Ching Huang
    Chia-I Shen
    Yung-Hung Luo
    Yuh-Min Chen
    Chao-Hua Chiu
    Teh-Ying Chou
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5 - 14
  • [40] Impact of sequential therapy with osimertinib on the overall survival in patients with EGFR-mutant non-small cell lung cancer
    Minehiko Inomata
    Masahiro Matsumoto
    Isami Mizushima
    Kana Hayashi
    Zenta Seto
    Kotaro Tokui
    Chihiro Taka
    Seisuke Okazawa
    Kenta Kambara
    Shingo Imanishi
    Toshiro Miwa
    Ryuji Hayashi
    Shoko Matsui
    Kazuyuki Tobe
    [J]. The Egyptian Journal of Bronchology, 2022, 16
12345